Serum Institute of India seeks approval for its Covid vaccine Covidshield | Oneinda News
Video Credit: Oneindia - Duration: 01:22s - Published
Serum Institute of India seeks approval for its Covid vaccine Covidshield | Oneinda News
After American firm Pfizer sought approval from the drug regulator, Serum Institute of India, the world's largest vaccine maker by number of doses produced, has sought government approval for emergency use authorisation of the coronavirus vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca.
Serum Institute of India partnered with AstraZeneca to conduct trials on its Covishield vaccine in India.
Adar Poonawala tweeted, As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD.
![Covid-19 vaccine dry run to be conducted in all states/UTs on January 2nd| Oneindia News [Video]](https://video.newsserve.net/300/v/20201231/1314875626-Covid-19-vaccine-dry-run-to-be-conducted.jpg)
![Matt Hancock hails 'significant moment' as Oxford Covid-19 jab given green light [Video]](https://video.newsserve.net/300/v/20201230/2012300807-Matt-Hancock-hails-significant-moment-as-Oxford-Covid.jpg)
!['India will get 50% of everything...': World's largest vaccine-maker, SII [Video]](https://video.newsserve.net/300/v/20201229/2012290423-India-will-get-50-of-everything.jpg)
